ghk-cu fda status adds non-injectable back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 of the 503A bulks process after the nomination was withdrawn from further review… GHK-Cu Dosage: Protocols & Charts
Description
But the conversion is straightforward once you understand the relationship

100% online

This is given through an intramuscular injection

Nasal deliverys proximity to the olfactory nerve pathway provides a potential direct CNS access route that has generated specific research interest in intranasal neuropeptide delivery studies making the nasal spray format a distinct and research relevant presentation compared to injectable DSIP preparations for protocols examining central neuropeptide activity
